EXORPHIA
EXORPHIA is a biotech company in Tokyo, Japan, founded in 2019.
Protecting Health with Nature's Drug
- Headquarters
- Tokyo
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- exorphia.com
About
EXORPHIA is a Tokyo-based biotechnology company developing extracellular vesicle (EV) technology for reproductive medicine. Its lead product is an acellular EV-containing supplement for in vitro fertilization (IVF) embryo culture, designed to improve embryo quality and IVF outcomes. Founded in 2019, the company collaborates with leading Japanese academic institutions including the University of Tokyo and Mie University.
Summary
It lists 1–10 employees.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/exorphia"><img src="https://indexed.vc/api/badge/company/exorphia" alt="EXORPHIA on Indexed.vc" width="260" height="76" /></a>